我院2年来处方评价的实践与体会
Practice and experience of prescription evaluation program in the hospital in recent two years
-
摘要: 目的: 总结处方评价的工作体会,与同行进行交流。 方法: 2007年7月-2009年7月每月随机抽取处方120张填写处方评价表;计算各评价指标平均值。 结果: 平均每张处方用药品种数为未超过WHO制定的标准,平均每张处方抗菌药物和注射剂使用百分率分别高于WHO制定的标准;内科平均每张处方用药金额为最高。 结论: 从总结工作体会的角度出发,提出处方评价具有较强的操作性、灵活性及实用性;具有对处方动态监测的功能;评价指标体系符合各科用药的特点;体现了惠及百姓的国家医改政策的观点。Abstract: Objective To conclude the Practice and experience of prescription evaluation program. Methods To take a sample of 120 prescriptions every month during July 2007 to July 2009,calculate the average of each indicator of the prescription evaluation table designed by the Ministry of Health. Results average numbers of drugs per prescription was under the line set by WHO,average numbers of antibiotic drugs per prescription and injections per prescription were over the line set by WHO,average amount per prescription of medical department was the most. Conclusion prescription evaluation program has great operability,flexibility and practicability,and could monitor the prescribing dynamically.The indicator system of the program is coincidence with the regular of drug utilization and the concept of national medical revolution policy which put much emphasis on caring the popular.
期刊类型引用(14)
1. Tian-tian Meng,Ya-ping You,Min Li,Jian-bo Guo,Xin-bin Song,Jing-yi Ding,Xiao-long Xie,An-qi Li,Shang-jin Li,Xiang-jun Yin,Peng Wang,Zhe Wang,Bao-liang Wang,Qing-yong He. Chinese herbal medicine Ginkgo biloba L. preparations for ischemic stroke:An overview of systematic reviews and meta-analyses. Journal of Integrative Medicine. 2024(02): 163-179 . 必应学术
2. 陈培培,马宏威,赵庆玲. 银杏二萜内酯对急性脑梗死患者血清slCAM-1、PTX-3、ET-1的影响. 世界复合医学(中英文). 2024(06): 30-33 . 百度学术
3. 王乐乐,强伟杰,王建军,葛卫红. 银杏二萜内酯葡胺注射液的药理作用及临床应用研究进展. 中国药科大学学报. 2024(06): 837-844 . 百度学术
4. 冯艳芳. 银杏二萜内酯葡胺注射液联合氯吡格雷治疗冠心病合并脑梗死的临床分析. 临床研究. 2023(02): 122-125 . 百度学术
5. 鞠晓宇,赵越,关胜江,程杰. 银杏叶类注射剂治疗脑梗死的Mini卫生技术评估. 临床合理用药. 2023(26): 10-15 . 百度学术
6. 尹庆娜,龚晓慧. 银杏二萜内酯葡胺注射液联合奥拉西坦治疗脑梗死恢复期对认知功能及血液流变学的影响. 中国医学创新. 2022(02): 73-77 . 百度学术
7. 李瑾,高晓红,王玉梅. 银杏二萜内酯葡胺注射液治疗急性脑梗死的疗效及对患者血清炎性因子水平的影响. 临床合理用药杂志. 2022(19): 11-14 . 百度学术
8. 潘亮发,邱小山,曾瑛. 银杏二萜内酯葡胺注射液治疗脑梗死恢复期的临床疗效及其对患者血液流变学的影响. 临床合理用药杂志. 2022(27): 12-14+19 . 百度学术
9. 刘保成. 观察银杏二萜内酯葡胺注射液联合丁苯酞治疗急性脑梗死的近远期效果. 智慧健康. 2021(24): 184-186 . 百度学术
10. 冼丽梅. 银杏二萜内酯葡胺注射液联合奥拉西坦对脑梗死恢复期治疗的临床观察. 北方药学. 2021(04): 11-12 . 百度学术
11. 郭春雷. 丁苯酞联合银杏二萜内酯葡胺治疗急性脑梗死的临床疗效及安全性研究. 中国现代医生. 2020(09): 134-136+140 . 百度学术
12. 路言琴,赵蕾,谢军. 探究银杏二萜内酯葡胺注射液对脑梗死恢复期患者的影响. 贵州医药. 2020(08): 1214-1215 . 百度学术
13. 包太成,彭梅. 银杏二萜内酯葡胺注射液治疗急性进展性脑梗死临床效果分析. 黑龙江中医药. 2019(03): 1-2 . 百度学术
14. 董正斌,张娜. 银杏二萜内酯葡胺注射液治疗急性脑梗死的效果分析. 中国误诊学杂志. 2019(12): 535-536 . 百度学术
其他类型引用(4)
-

计量
- 文章访问数: 2353
- HTML全文浏览量: 200
- PDF下载量: 513
- 被引次数: 18